Skip to main content
. 2024 Jan 27;16(1):228–238. doi: 10.4240/wjgs.v16.i1.228

Figure 2.

Figure 2

A forest graph showing the outcomes of a meta-analysis of standardized mean differences between responders and non-responders, remitters and non-remitters, and mucosal healers and non-healers of anti-tumor necrosis factor-based therapies in patients with inflammatory bowel disease. OSM: Oncostatin M; TNF: Tumor necrosis factor; SMD: Standardized mean difference.